Mechanical Stress Effects on the Cardiovascular Adaptations of Peripheral Arterial Calcifications Among Athletes
NCT ID: NCT01577576
Last Updated: 2015-11-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
56 participants
OBSERVATIONAL
2012-09-30
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A. Determine the presence and extent of intima-media calcifications in athletes B. Determine the relationship between these calcifications and the level, length and intensity of sports activity.
C. Determine the relationship between these properties and calcification of the arterial wall D. Analyze the relationship between the type of sports activity and properties of the arterial wall.
E. Examine the relationship between the properties of the arterial wall and peripheral perfusion pressures.
F. Examine the relationship between the properties of the arterial wall, changes in afterload, morphology and systolic heart function.
G. Analyze the relationships between the parameters characterizing the arterial wall and muscle mass of the lower limbs.
H. Analyze the relationship between the presence of intramural calcification and bone density determined by densitometry.
I. Analyze the relationship between the presence of intramural calcification and dietary protein intake and calcium.
J. Compare indices of pressure at the ankle and toe, depending on the extent of calcification.
K. Create a collection of biological samples (serum).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Upper-body athletes
This group includes swimmers, rowers or kayakers with a history of at least 10 years of intense training, and performance in regional competitions for the past five years.
No interventions assigned to this group
Lower-body athletes
This group includes runners (marathon or trail) and cyclists with a history of at least 10 years of intense training, and performance in regional competitions for the past five years.
No interventions assigned to this group
Sedentary volunteers
This group of healthy volunteers does not participate in athletic activity for more than two hours per week. They are matched by age and sex with the athletic groups.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The volunteer must be insured or beneficiary of a health insurance plan
* Volunteers without cardiovascular disease, glucose regulation disorders or known renal disease
* Ongoing athletic activity for the past 10 years
* Athletic activity at the regional level for the past 5 years
* Practices one of the three following sports: marathon, trail running, cycling.
Exclusion Criteria
* The volunteer is in an exclusion period determined by a previous study
* The volunteer is under judicial protection, under tutorship or curatorship
* The volunteer refuses to sign the consent
* It is impossible to correctly inform the volunteer
* The volunteer is pregnant, parturient, or breastfeeding
* Tobacco use
* Contraindications for the practice of physical activity (joint, heart or other)
* Intercurrent pathology
* First degree family history of cardiovascular disease
* Known dyslipidemia (including cholesterol)
* Glucose tolerance abnormalities (prediabetes or diabetes)
* Treatment with certain drugs used for treating erectile dysfunction: Sildefanil (Viagra), Tadalafil (Cialis), Vardenafil (Levitra) and yohimbine (Yohimbine Houde and Yocoral)
* More than two hours of athletic activity per week
* History of intense athletic training
* Body mass index \>= 25 kg/m\^2
25 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonia Perez Martin, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université d'Avignon, Faculté des Sciences
Avignon, , France
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-A00475-38
Identifier Type: OTHER
Identifier Source: secondary_id
LOCAL/2012/APM-01
Identifier Type: -
Identifier Source: org_study_id